Crotalaria juncea Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Papilionaceae; Fabaceae. |
| Habitat | Throughout the plains of India, especially in South India. |
| English | Sun Hemp. |
| Ayurvedic | Shana, Shanapushpi, Malyapushpa. |
| Unani | Sunn. |
| Siddha / Tamil | Sanal, Manji, Sannappu. |
| Folk | Jhanjhaniaa. |
| Action | Leaf—demulcent, purgative, emetic, emmenagogue, abortifacient, ant-implantation. Given in diarrhoea, dysentery and bleeding disorders. Seeds—used in psoriasis and impetigo. |
| Dosage | Seed—1–3 g powder. (API Vol. III.) |
| Taxonomic Cohort | Genus Crotalaria (2 documented species); Family Papilionaceae (67 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Crotalaria juncea (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Papilionaceae; Fabaceae (primary family classification: Papilionaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Throughout the plains of India, especially in South India.
Across classical and vernacular Indian systems of medicine, Crotalaria juncea is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Sun Hemp; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Shana, Shanapushpi, Malyapushpa; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Sunn; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Sanal, Manji, Sannappu; in regional Indian folk and vernacular ethnobotany as Jhanjhaniaa. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Crotalaria juncea are: Leaf—demulcent, purgative, emetic, emmenagogue, abortifacient, ant-implantation. Given in diarrhoea, dysentery and bleeding disorders. Seeds—used in psoriasis and impetigo. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Crotalaria juncea establish the following evidence base: Seeds—hepatotoxic. Seed oil gave fatty acids—linoleic, linolenic and oleic. Pyrrolizidine alkaloids—junceine, tricodesmine, riddelline, seneciphylline and senecionine were also obtained.
In specialized pharmacognostic classifications, Crotalaria juncea is also represented by authenticated macro-photographic crude drug specimens in institutional pharmacognostic collections.

Figure 1: Authenticated crude herb specimen — Crotalaria juncea seed.

Botanical Reference 1: Crotalaria juncea — Botanical specimen

Botanical Reference 2: Crotalaria juncea — Botanical specimen

Botanical Reference 3: Crotalaria juncea — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Crotalaria comprises 2 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Crotalaria verrucosa (Action: Juice of leaves—used for biliousness, dyspepsia, blood impurities, scabies and…). Comparing Crotalaria juncea alongside its congeners in genus Crotalaria highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Papilionaceae encompasses 67 documented medicinal species (3.69% of the 1,814-species flora). Other representative medicinal members of Papilionaceae include: Abrus precatorius Linn. (Gunjaa), Alhagi pseudalhagi (Yavaasaka), Arachis hypogaea (Mandapi), Atylosia goensis (Maashaparni), Butea monosperma (Paalasha). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 2: Quantitative documentation profile across all 67 medicinal species of family Papilionaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
For clinical and traditional dispensing, the standardized posology and crude herb dosage for Crotalaria juncea are prescribed as follows: Seed—1–3 g powder. (API Vol. III.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Crotalaria juncea integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.